In advanced PACG eyes with 360° angle closure, the differences between the 12-month IOP control, surgical success, and medication reduction of the two groups.

To determine if changes in UCDVA, UCIVA, UCNVA, and low-contrast CDVA (10% & 25%) post-phacoemulsification with PCIOLs are linked to preoperative HOA values.

Evaluating real world anatomical, visual and safety outcomes of combined intraoperative IVTA and phacoemulsification cataract surgery in eyes with DME history.

Long-Term Safety and Effectiveness of STREAMLINE Canaloplasty with Phacoemulsification in a Hispanic Population with Open-Angle Glaucoma

To evaluate 24-month safety and effectiveness of excimer laser trabeculostomy combined with phacoemulsification in patients with mild-to-moderate primary open-angle glaucoma (POAG).

Clinically nonsignificant incision-site Descemet membrane detachment appears to be a frequent intraoperative morphological phenomenon during phacoemulsification

Background/aims Minimally invasive glaucoma surgery (MIGS) procedures are commonly combined with phacoemulsification to provide additional intraocular pressure (IOP) and/or topical medication reduction in patients with mild-to-moderate glaucoma. This study compared the 1-year efficacy and safety of excimer laser trabeculostomy (ELIOS) versus trabecular micro-bypass stenting (iStent inject and iStent inject W), both performed in combination with cataract surgery.Methods This multicentre retrospective cohort study included patients undergoing combined phacoemulsification with either ELIOS (Phaco-ELIOS) or iStent implantation (Phaco-iStent) at three European centres between 2020 and 2025. The primary endpoint was IOP at 12 months postoperatively. Secondary endpoints included longitudinal IOP and medication use, surgical success, adverse events and the need for secondary glaucoma surgery. Longitudinal outcomes were analysed using multiple imputation.Results A total of 343 eyes were included (164 Phaco-ELIOS and 179 Phaco-iStent), with 1-year follow-up available in 70%. Mean IOP decreased by 21.6% for Phaco-ELIOS and 20.7% for Phaco-iStent and remained stable through 12 months (p=0.74). Both procedures were associated with a similar reduction in postoperative topical glaucoma medications (0.56 vs 0.41; p=0.2). With Phaco-ELIOS, a higher proportion of eyes achieved medication reduction (46.4% vs 31.3%; p=0.02). Rates of adverse events and secondary glaucoma surgery were low and comparable in both groups.Conclusion Phaco-ELIOS and Phaco-iStent provided comparable 1-year IOP reduction and overall safety. Phaco-ELIOS showed a greater number of patients with topical medication reduction, supporting its role as an effective combined MIGS option in patients undergoing cataract surgery.

Background To investigate whether phacoemulsification platform type and phaco tip design are associated with differences in unadjusted posterior capsular rupture (PCR) rates in cataract surgery.Methods This retrospective observational study used centre-level data from UK National Health Service (NHS) cataract surgery centres included in the 2024 National Ophthalmology Database Cataract Audit, with a complementary analysis from two tertiary NHS centres. Phacoemulsification platform and principal tip design were identified by contacting each centre. Unadjusted PCR rates were compared using ² tests with ORs and 95% CIs. A separate eye-level analysis assessed the association between tip design and PCR after adjusting for surgeon experience.Results Twenty-four NHS centres contributed 166 213 cataract operations, with a mean unadjusted PCR rate of 1.48% (SD 0.61%). Among 44 202 procedures, Alcon systems accounted for 25 921 cases with 462 PCRs (1.78%), while Bausch & Lomb systems accounted for 18 281 cases with 202 PCRs (1.10%) (OR 1.62, 95% CI 1.38 to 1.92; p

In this column, I invite Drs. Rohit Om Parkash and Tushya Om Parkash to share their experience with stratified phacoemulsification, an evolution of nuclear management that emphasizes preservation of a protective nuclear scaffold during surgery. Amar Agarwal, MS, FRCS, FRCOphth OSN Complications Consult Editor In phacoemulsification, surgical maneuvers, ultrasound energy and surrounding structural integrity determine surgical outcomes. Preserving the outer nucleus or epinucleus helps protect the posterior capsule and improve safety in complex cataract phacoemulsification. In the literature, Drs.

Click here to read the Cover Story, “‘Embrace the future’ of robotics in ophthalmology.” Ophthalmology has a history of integrating innovation, from phacoemulsification and IOLs to advanced imaging, lasers and minimally invasive surgical techniques. Each transition has required surgeons to rethink how they learned, how they made decisions and how they defined excellence. As robot-assisted ophthalmic surgery moves from concept to clinical reality, the field will need to evolve in the same way it always has: by combining deep respect for surgical fundamentals with a willingness to adopt

Click here to read the Cover Story, “‘Embrace the future’ of robotics in ophthalmology.” Ophthalmology has a history of integrating innovation, from phacoemulsification and IOLs to advanced imaging, lasers and minimally invasive surgical techniques. Each transition has required surgeons to rethink how they learned, how they made decisions and how they defined excellence. As robot-assisted ophthalmic surgery moves from concept to clinical reality, the field will need to evolve in the same way it always has: by combining deep respect for surgical fundamentals with a willingness to adopt

To evaluate the intraocular pressure (IOP)-lowering effect, adverse event profile, and risk factors for failure of an ab externo microshunt combined with phacoemulsification after 1 year of follow-up.

We write to comment on the article published in Ophthalmology Glaucoma,1 which reports outcomes after phacoemulsification combined with Hydrus microstent (phaco–Hydrus). Although the subject is clinically relevant, this study is methodologically compromised, which significantly limits the validity of its conclusions and, in our view, leads to a misrepresentation of treatment efficacy in the reported cohort.

Eye, Published online: 22 July 2026; doi:10.1038/s41433-026-04749-xOutcomes of phacoemulsification combined with ab interno trabeculotomy: stratified by incision extent, glaucoma severity, and baseline number of medications

YouTube video by EyeSmart — American Academy of Ophthalmology

Researchers evaluated the risk of incident glaucoma in older adults undergoing combined phacovitrectomy versus sequential phacoemulsification.

To investigate topical anesthesia in patients undergoing phacoemulsification cataract surgery & femtosecond laser-assisted cataract surgery (FLACS).

Toric intraocular lenses (IOL) are an effective option for restoring visual acuity and correcting preexisting corneal astigmatism in patients undergoing phacoemulsification.1–3 Achieving postoperative emmetropia and optimal refractive and visual outcomes requires accurate correction of preexisting corneal astigmatism.1,2 In a large population-based study from the United Kingdom including more than 110,000 eyes of patients aged over 65 years, corneal astigmatism of at least 0.5 diopters (D) was present in 78% of included eyes.

Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.” Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and enhance our patients’ vision. Notable examples include Sir Harold Ridley and the intraocular lens; Charles Kelman, MD, and phacoemulsification; Richard Hill, MD, and MIGS; Steve Trokel, MD, and excimer laser corneal refractive surgery; Alan Scott, MD, and Botox; Gerhard Meyer-Schwickerath, MD, and retinal photocoagulation; and Philip Rosenfeld, MD, PhD, and intravitreal

Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.” Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and enhance our patients’ vision. Notable examples include Sir Harold Ridley and the intraocular lens; Charles Kelman, MD, and phacoemulsification; Richard Hill, MD, and MIGS; Steve Trokel, MD, and excimer laser corneal refractive surgery; Alan Scott, MD, and Botox; Gerhard Meyer-Schwickerath, MD, and retinal photocoagulation; and Philip Rosenfeld, MD, PhD, and intravitreal

This aims to compare endothelial cell loss (ECL) after cataract phacoemulsification surgery between eyes with microcornea and those with normal-sized corneas.

Two methods of cataract surgery — phacoemulsification and manual small-incision cataract surgery — can lead to “acute detrimental effects on the ocular surface,” including dry eye and increased inflammation, according to a study. “Cataract surgery is ... responsible for transiently inducing or exacerbating dry eye, and several studies have shown that uncomplicated phacoemulsification can increase dry eye symptoms,” Geeta Behera, of the department of ophthalmology at Jawaharlal Institute of Post-Graduate Medical Education and Research, India, and colleagues

Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.” Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and enhance our patients’ vision. Notable examples include Sir Harold Ridley and the intraocular lens; Charles Kelman, MD, and phacoemulsification; Richard Hill, MD, and MIGS; Steve Trokel, MD, and excimer laser corneal refractive surgery; Alan Scott, MD, and Botox; Gerhard Meyer-Schwickerath, MD, and retinal photocoagulation; and Philip Rosenfeld, MD, PhD, and intravitreal